What's new? Log in Free sign up

Hologic (HOLX)

Company Profile

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

Company profile

Ticker

HOLX

Exchange

Website

www.hologic.com

CEO

Stephen MacMillan

Incorporated

Location

Fiscal year end

Sector

Manufacturing > Irradiation Apparatus Manufacturing

Industry (SIC)

X-Ray Apparatus & Tubes & Related Irradiation Apparatus

GE HealthCare • Butterfly Network • Nano X Imaging • Check-Cap • Grapefruit USA • Koninklijke Philips ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Acessa Health Inc. • Beijing Hologic Technology Co., Ltd. • Benassar Diagnostica-Equipamientos Medicos Unipessoal, Lda. • BioLucent, LLC • Bioptics, Inc. • Biotheranostics, Inc. • Bolder Surgical Holdings, Inc. • Bolder Surgical, LLC • Cytyc Corporation • Cytyc Prenatal Products Corp. ...

IRS number

42902449

HOLX stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$93.50

Low target

$85.00

High target

$105.00

Latest filings (excl ownership)

View all

Conflict minerals disclosure

Registration of securities for employees

Quarterly report

2 May 23

Results of Operations and Financial Condition

Departure of Directors or Certain Officers

Departure of Directors or Certain Officers

Results of Operations and Financial Condition

Quarterly report

1 Feb 23

Additional proxy soliciting materials

Definitive proxy

19 Jan 23

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Notice of proposed sale of securities

Essex D Mitchell

Notice of proposed sale of securities

Amy McBride Wendell

Stacey D. Stewart

Christiana Stamoulis

SCOTT T GARRETT

Charles J Dockendorff

Financial summary

Financial statements Chart HOLX financial data

Quarter (USD)	Apr 23	Dec 22	Sep 22	Jun 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Sep 22	Sep 21	Sep 20	Sep 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Hologic earnings reports.

Recent insider trades

HOLX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 May 23	Essex D Mitchell	Common Stock	Sell	Dispose S	No	No	83.7302	2,390	200.12 k	7,212
9 Mar 23	Sally Crawford	Common Stock	Grant	Acquire A	No	No	0	1,465	0.00	131,355
9 Mar 23	Sally Crawford	NQSO Common Stock	Grant	Acquire A	No	No	78.49	4,210	330.44 k	4,210
9 Mar 23	Ludwig Hantson	Common Stock	Grant	Acquire A	No	No	0	1,465	0.00	9,520
9 Mar 23	Ludwig Hantson	NQSO Common Stock	Grant	Acquire A	No	No	78.49	4,210	330.44 k	4,210
9 Mar 23	Scott T Garrett	Common Stock	Grant	Acquire A	No	No	0	1,465	0.00	67,039
9 Mar 23	Scott T Garrett	NQSO Common Stock	Grant	Acquire A	No	No	78.49	4,210	330.44 k	4,210
9 Mar 23	Namal Nawana	Common Stock	Grant	Acquire A	No	No	0	1,465	0.00	18,221
9 Mar 23	Namal Nawana	NQSO Common Stock	Grant	Acquire A	No	No	78.49	4,210	330.44 k	4,210

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Hologic Announces FDA Clearance Of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay

Multiplexed Respiratory Test Now Available in the U.S. With New RespDirect Collection Kit Hologic Inc. (NASDAQ:HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the

New Breast Cancer Guidelines Say To Start Screenings At Age 40, Instead Of 50

What 9 Analyst Ratings Have To Say About Hologic

Morgan Stanley Maintains Equal-Weight on Hologic, Raises Price Target to $86

RBC Capital Reiterates Sector Perform on Hologic, Maintains $87 Price Target

Press releases

From Benzinga Pro

Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay

Multiplexed Respiratory Test Now Available in the U.S. With New RespDirect Collection Kit Hologic Inc. (NASDAQ:HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for

Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family

MARLBOROUGH, Mass., May 16, 2023 /PRNewswire/ -- Hologic, Inc. (NASDAQ:HOLX), a global leader in women's health, announced a new partnership with recently drafted NFL cornerback Kelee Ringo and his mother, breast

Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family

Ringo and His Mother Will Reinforce the Importance of Annual Mammograms Hologic Inc. (NASDAQ:HOLX), a global leader in women's health, today announced a partnership with recently drafted NFL cornerback Kelee Ringo and

Hologic to Webcast Presentation at the BofA Securities 2023 Healthcare Conference

Hologic Announces Financial Results for Second Quarter of Fiscal 2023

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.